[{"NetIncomeLoss_1_Q2_USD":-15824000.0,"OperatingLeaseLiability_0_Q2_USD":5847000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12080000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5960000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":223594118.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":246966143.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":127285000.0,"InterestAndOtherIncome_2_Q2_USD":1229000.0,"InterestAndOtherIncome_1_Q2_USD":475000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":57000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":10285000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":189000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-97048000.0,"Depreciation_2_Q2_USD":60000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":3389000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":73000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":937000.0,"AssetsCurrent_0_Q2_USD":220743000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":82000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":913000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":3821000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":242104000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":313000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1362373000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":73000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":78012000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":227000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":422000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-3000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":41000.0,"CommonStockValue_0_Q2_USD":310000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":46223000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":987000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":82000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":21647000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":144951000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":73000.0,"GainOnSaleOfInvestments_2_Q2_USD":19000.0,"AssetsFairValueAdjustment_2_Q2_USD":-279000.0,"RestrictedInvestmentsAtFairValue_0_Q2_USD":363000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-32122000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-15511000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":22865000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4991000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":10845000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":8067000.0,"Assets_0_Q2_USD":274814000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":5492000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":34000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":3855000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1112191000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":182355000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":258000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1707000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38589000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":7681000.0,"LiabilitiesCurrent_0_Q2_USD":19142000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":241919000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":9314000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":812000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":20628000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":20624000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":23228000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":32000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":127285000.0,"IncreaseDecreaseInOperatingAssets_2_Q2_USD":-389000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":734000.0,"NetIncomeLoss_2_Q2_USD":-32179000.0,"AccountsPayableCurrent_0_Q2_USD":3797000.0,"ShareBasedCompensation_2_Q2_USD":3275000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":386000.0,"ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity_1_Q2_USD":16000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":4075000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2220000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":962000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":95000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":43000.0,"OperatingIncomeLoss_2_Q2_USD":-33632000.0,"OperatingIncomeLoss_1_Q2_USD":-16762000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":195881000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":274814000.0,"StockholdersEquity_0_Q2_USD":250681000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4204000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1707000.0,"NontradeReceivablesCurrent_0_Q2_USD":822000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":856000.0,"OperatingExpenses_2_Q2_USD":33727000.0,"OperatingExpenses_1_Q2_USD":16805000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":363000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.14,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.06,"ProfitLoss_2_Q2_USD":-32179000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3275000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":447000.0,"Ticker":"GERN","CIK":"886744","name":"GERON CORP","OfficialName":"Geron Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"565597388.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]